<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343076">
  <stage>Registered</stage>
  <submitdate>18/06/2011</submitdate>
  <approvaldate>23/06/2011</approvaldate>
  <actrnumber>ACTRN12611000638932</actrnumber>
  <trial_identification>
    <studytitle>Impact of pre-operative misoprostol on blood loss during and after elective cesarean delivery.</studytitle>
    <scientifictitle>Impact of pre-operative misoprostol on blood loss during and after elective cesarean delivery.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>blood loss during and after cesarean delivery</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>preoperative adminstration of 400 microgram rectal misoprostol immediately before skin incision.</interventions>
    <comparator>there is control group receiving the standard care which means starting oxytocin infusion in the rate of 340miu/min. after cord clamping.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Amount of blood loss during cesarean delivery assessed by graduated suction machine  .</outcome>
      <timepoint>During the operation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Amount of post-partum blood loss during first 24 hours after delivery by pad weighing.</outcome>
      <timepoint>within 24 hours of delivery.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Difference in hematocrit between pre and post-operative values.</outcome>
      <timepoint>24 hours after delivery.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Apgar score of the neonate.</outcome>
      <timepoint>1 and 5 minutes after delivery</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>elective cesarean, full-term pregnancy, normal blood indices, non-compromised average weight fetus.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>labour pains, multiple pregnancy, bleeding disorder or thrombophilia, abnormal placenta(previa or accreta by ultrasound, fetal distress, preterm fetus.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Computer program, sealed envelopes, opened in theater.</concealment>
    <sequence>counseling of all eligible women, informed consent then randomization using computer program.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/01/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>400</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Mervat Sheikh Elarab Elsedeek Omran</primarysponsorname>
    <primarysponsoraddress>49 Elhoreya street Janaclis, Elraml district, Alexandria, Egypt.
post code 03312</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Mervat Sheikh Elarab Elsedeek Omran</fundingname>
      <fundingaddress>649 Elhoreya street Janaclis, Elraml district, Alexandria, Egypt.
post code 03312</fundingaddress>
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study was to evaluate the efficacy of rectal misoprostol in reducing blood loss during and after cesarean delivery.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The ethics committee of Alexandria faculty of medicine, Alexandria university.</ethicname>
      <ethicaddress>Alexandria faculty of medicine, Alexandria university, Alexandria, Egypt.
post code 03312</ethicaddress>
      <ethicapprovaldate>29/05/2007</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Mervat Sheikh elarab Elsedeek</name>
      <address>649 elhoreya street, Janaclis, Elraml District, Alexandria, Egypt.
post code 03312</address>
      <phone>+203 5759915</phone>
      <fax />
      <email>mervatsheikhelarab@yahoo.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mervat Sheikh elarab Elsedeek</name>
      <address>649 elhoreya street, Janaclis, Elraml District, Alexandria, Egypt.
post code 03312</address>
      <phone>+203 5759915</phone>
      <fax />
      <email>mervatsheikhelarab@yahoo.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mervat Sheikh elarab Elsedeek</name>
      <address>649 elhoreya street, Janaclis, Elraml District, Alexandria, Egypt.
post code 03312</address>
      <phone>+203 5759915</phone>
      <fax />
      <email>mervatsheikhelarab@yahoo.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>